NexImmune, Inc. Profile Avatar - Palmy Investing

NexImmune, Inc.

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its p…

Biotechnology
US, Gaithersburg [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of NEXI's Analysis
CIK: 1538210 CUSIP: 65344D109 ISIN: US65344D2080 LEI: - UEI: -
Secondary Listings
NEXI has no secondary listings inside our databases.